These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15312442)

  • 1. [The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].
    Lian XL; Bai Y; Dai WX; Jin ZM; Zeng ZP; Guo ZS
    Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):442-6. PubMed ID: 15312442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study.
    Kim HJ; Kim BH; Han YS; Yang I; Kim KJ; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    Am J Gastroenterol; 2001 Jan; 96(1):165-9. PubMed ID: 11197248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propylthiouracil-induced overt hepatic injury in patients with hyperthyroidism].
    Lian XL; Bai Y; Dai WX; Guo ZS; Li W; Lu L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):172-7. PubMed ID: 15171556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Asymptomatic hepatitis induced by propylthiouracil].
    De Castro JJ; Nobre EL; Garcia e Costa J; Galvão-Teles A
    Acta Med Port; 2001; 14(5-6):523-7. PubMed ID: 11878166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
    Li MT; Zeng XJ; Fang WG; Li H; Li XM; Feng K; Li YZ; Zeng XF; Zhang FC; Tang FL
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2082-5. PubMed ID: 15730621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver tests in hyperthyroidism: effect of antithyroid therapy.
    Gürlek A; Cobankara V; Bayraktar M
    J Clin Gastroenterol; 1997 Apr; 24(3):180-3. PubMed ID: 9179740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hyperthyroidism and propylthiouracil treatment on liver biochemical tests.
    Aydemir S; Bayraktaroglu T; Demircan N; Sert M; Açikgoz S; Tekin IO; Ustundag Y
    Int J Clin Pract; 2005 Nov; 59(11):1304-8. PubMed ID: 16236085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study.
    Liaw YF; Huang MJ; Fan KD; Li KL; Wu SS; Chen TJ
    Ann Intern Med; 1993 Mar; 118(6):424-8. PubMed ID: 8439116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
    Gao Y; Chen M; Ye H; Yu F; Guo XH; Zhao MH
    Rheumatology (Oxford); 2008 Oct; 47(10):1515-20. PubMed ID: 18676500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoring.
    Primeggia J; Lewis JH
    J Natl Med Assoc; 2010 Jun; 102(6):531-4. PubMed ID: 20575220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.
    Huang MJ; Li KL; Wei JS; Wu SS; Fan KD; Liaw YF
    Am J Gastroenterol; 1994 Jul; 89(7):1071-6. PubMed ID: 7912472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in liver biochemical tests at diagnosis and after propylthiouracil therapy for hyperthyroidism.
    Gürlek A; Cobankara V; Bayraktar M
    Mater Med Pol; 1996; 28(3):103-6. PubMed ID: 9167420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The propylthiouracil dilemma.
    Glinoer D; Cooper DS
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):402-7. PubMed ID: 22820213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propylthiouracil hepatitis: report of a case and extensive review of the literature.
    Memi E; Karras S; Tzotzas T; Krassas GE
    J Pediatr Endocrinol Metab; 2012; 25(3-4):331-43. PubMed ID: 22768665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propylthiouracil-induced severe hepatitis: a case report and review of the literature.
    Ichiki Y; Akahoshi M; Yamashita N; Morita C; Maruyama T; Horiuchi T; Hayashida K; Ishibashi H; Niho Y
    J Gastroenterol; 1998 Oct; 33(5):747-50. PubMed ID: 9773944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propylthiouracil-induced hepatic damage.
    Ozenírler S; Tuncer C; Boztepe U; Akyol G; Alkim H; Cakir N; Kandílć U
    Ann Pharmacother; 1996 Sep; 30(9):960-3. PubMed ID: 8876856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
    Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
    Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
    Yang J; Li LF; Xu Q; Zhang J; Weng WW; Zhu YJ; Dong MJ
    Thyroid; 2015 Mar; 25(3):278-83. PubMed ID: 25384184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
    Hackmon R; Blichowski M; Koren G
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive crescentic glomerulonephritis induced by propylthiouracil (PTU)].
    Kato H; Osajima A; Tanaka H; Serino R; Kabashima N; Tamura M; Segawa K; Anai H; Takasugi M; Nakajima Y
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):517-22. PubMed ID: 9283219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.